Literature DB >> 26835352

Neonatal rhabdomyosarcoma: an unusual presentation.

Shachi Jain Taran1, Rakesh Taran1, Advait Prakash1, Ravindra Kumar1, Sangram Singh1.   

Abstract

Though rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in the paediatric age group, its occurrence in new born is rare. Often it presents as a large mass arising from anywhere in the body, most common site being head and neck region. Here we are describing a case of neonatal embyonal RMS with multiple subcutaneous nodules.

Entities:  

Keywords:  Rhabdomyosarcoma (RMS); embryonal; paraneonate

Year:  2014        PMID： 26835352      PMCID： PMC4728838          DOI： 10.3978/j.issn.2224-4336.2014.07.04

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN： 2224-4336


  7 in total

1.  Blueberry muffin rash as a presentation of alveolar cell rhabdomyosarcoma in a neonate.

Authors:  S V Godambe; J Rawal
Journal:  Acta Paediatr       Date:  2000-01       Impact factor: 2.299

2.  Cutaneous metastases in neonates: a review.

Authors:  Hart Isaacs
Journal:  Pediatr Dermatol       Date:  2011 Mar-Apr       Impact factor: 1.588

3.  Neonatal rhabdomyosarcoma: the IRS experience.

Authors:  T E Lobe; E S Wiener; D M Hays; W H Lawrence; R J Andrassy; J Johnston; M Wharam; B Webber; A Ragab
Journal:  J Pediatr Surg       Date:  1994-08       Impact factor: 2.545

4.  An unusual localization of embryonal rhabdomyosarcoma in a neonate.

Authors:  Aşkin Güra; Gülsün Tezcan; Güngör Karagüzel; Can Cevikol; Nihal Oygür
Journal:  Turk J Pediatr       Date:  2007 Jan-Mar       Impact factor: 0.552

5.  Primary cutaneous alveolar rhabdomyosarcoma of the perineum.

Authors:  Yun Gong; Jerome Chao; Bruce Bauer; Xiaoping Sun; Pauline M Chou
Journal:  Arch Pathol Lab Med       Date:  2002-08       Impact factor: 5.534

6.  Rhabdomyosarcomas with primary presentation in the skin.

Authors:  D Schmidt; C D Fletcher; D Harms
Journal:  Pathol Res Pract       Date:  1993-05       Impact factor: 3.250

7.  A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan.

Authors:  Hajime Hosoi; Satoshi Teramukai; Yoshifumi Matsumoto; Kunihiko Tsuchiya; Tomoko Iehara; Jun-ichi Hara; Tetsuo Mitsui; Michio Kaneko; Yoshiro Hatae; Yutaka Hayashi; Osamu Mabuchi; Naoto Adachi; Yasuhide Morikawa; Shin-ichiro Nishimura; Masaaki Kumagai; Hideo Takamatsu; Tadashi Sawada; Tohru Sugimoto
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.